Defined research compound
A melanocortin-receptor agonist with receptor and clinical literature; catalogue material is not an approved medicine.

REPRODUCTIVE / RESEARCH COMPOUND
Last listed prices · currently unavailable
Analytical results apply to a specific sample, batch and test method. Ask about the exact lot being offered; do not assume a generic purity figure or test panel applies to every batch.
Understand Batch Test Reports ↗For laboratory research use only. Not for human consumption. No treatment or self-administration guidance is provided.
PT-141, also known as bremelanotide, is a melanocortin-receptor agonist studied in human sexual-desire, sexual-arousal and receptor-pharmacology research.
A melanocortin-receptor agonist with receptor and clinical literature; catalogue material is not an approved medicine.
A melanocortin-receptor agonist with receptor and clinical literature; catalogue material is not an approved medicine.
Explore receptor targets and downstream signalling studied for this compound.
Engages central melanocortin receptor signalling.
View FDA pharmacology reviewAlso interacts with another central melanocortin receptor.
View FDA pharmacology reviewHas peripheral melanocortin receptor activity as well.
View FDA receptor reviewStudied as a brain-mediated melanocortin pathway.
View FDA pharmacology reviewExpand each group. Categories follow the linked Pep-Pedia source profile. Labels describe relative research emphasis and are not clinical efficacy grades.
FDA-approved for premenopausal women with acquired, generalized HSDD
Effective in men including those unresponsive to PDE5 inhibitors
Improves physiological and subjective arousal measures
Clinical trials show significant reduction in distress related to low sexual desire
Improvements in overall sexual satisfaction scores in both partners
Positive effects on relationship satisfaction and quality of life
No significant effects on glucose metabolism unlike some melanocortin agonists
Unlike Melanotan II, minimal effects on appetite or weight
Extensive safety data shows manageable cardiovascular profile
Pep-Pedia community poll distributions. Every response option returned for each displayed question is shown.
Anonymous self-reporting is subject to selection bias and is not clinical evidence. Percentages describe community responses and may not total exactly 100% because of rounding. Snapshot captured 2026-10-16; the source refreshes in the background.
Research context belongs beside—not above—the safety and evidence boundary.
* Source context: Pep-Pedia research profile ↗. This catalogue uses a research-only summary and does not reproduce protocol or self-use instructions.
First 30–45 minutes · mild nausea or facial flushing may occur
Around 45–90 minutes · increased arousal or desire may begin
Around 2–4 hours · the strongest sexual-response effects are commonly reported
Around 6–12 hours · effects generally fade gradually
Intermittent follow-up · the source reports no clear tolerance signal with intermittent studied use
Study type is part of the product information. Laboratory, animal, observational and controlled human findings are not interchangeable.
FDA-approved for premenopausal women with acquired, generalized HSDD
Clinical trials show significant reduction in distress related to low sexual desire
No significant effects on glucose metabolism unlike some melanocortin agonists
Batch COA checklist · Presentation and blend labels · Publisher and source policy
The last listed INR prices are 10 mg: ₹3,400. This product is currently sold out. Confirm availability, delivery charges and the final order total before payment.
PT-141 is a name used for Bremelanotide. Match the exact identity, labelled amount and batch records when comparing research listings. This catalogue vial is not a finished prescription product and does not provide instructions for human use.
PT-141; Bremelanotide are names used in material searches. A melanocortin-receptor research material. This vial listing is not a finished prescription product. Match the full label, form and batch documents; an alias alone does not authenticate a product.
Delivery enquiries are welcome for these cities and other Indian destinations, subject to the actual PIN code. Standard delivery: ₹150, estimated 3–5 days. Express delivery: ₹350, estimated 2–3 days. Cash on delivery adds ₹150. Confirm PIN-code serviceability and the delivery estimate before ordering.
Returns and refunds are available for products damaged on arrival or if purity is below 99%. Retain the order reference, packaging and relevant batch records; contact the team to confirm the claim process.
Select the labelled presentation and quantity, review the cart, then send the order enquiry on WhatsApp. Share your Indian PIN code so the team can confirm stock, serviceability, delivery charges and the final INR total before payment. This item is currently sold out; ask about availability rather than placing an order.
Use the batch COA request link on this page and specify the selected presentation. Ask the team to match available documentation to the current batch and confirm delivery to your Indian PIN code before payment. Compare the report identity, test method and measured result with the material offered.
Standard delivery across India costs ₹150 and usually takes 3–5 days. Express delivery costs ₹350 and usually takes 2–3 days. Cash on delivery is available for an extra ₹150. The team confirms serviceability for your PIN code and the final total on WhatsApp before dispatch.
Yes. The Peptide Co. ships from Bengaluru to eligible PIN codes across India, including Mumbai, Delhi NCR, Bengaluru (Bangalore), Hyderabad, Chennai, Pune, Kolkata and Ahmedabad. Share your PIN code on WhatsApp to confirm serviceability and the delivery estimate for your address.
PT-141 / Bremelanotide is also known as PT-141, Bremelanotide. These names describe the same listing on this page; always match the labelled identity and batch documentation rather than relying on a name alone.
As of 1 November 2026, this page shows one listed presentation for PT-141 / Bremelanotide, and prices on the page are read from the live catalogue each time it loads. The item is currently sold out. Your final total is confirmed on WhatsApp.
PT-141 / Bremelanotide is classified as defined research compound. A melanocortin-receptor agonist with receptor and clinical literature; catalogue material is not an approved medicine.
Its principal research areas are melanocortin receptor signalling, sexual-function research, central arousal pathways. These describe experimental topics, not guaranteed outcomes or approved indications.
10 mg lyophilized research material in a sealed glass vial. Appearance: White to off-white lyophilized powder. Always compare the received vial with its lot-specific documentation.
Keep sealed, dry and protected from light/moisture. Store at 2–8°C short-term and ≤−20°C long-term unless the batch documentation states otherwise.
Research material; not offered as an approved medicine. This catalogue presentation is restricted to laboratory research material and does not provide dosing, treatment or self-administration guidance.